Published in Gene Therapy Weekly, July 25th, 2002
Investigators at the Burnham Institute Cancer Center in La Jolla, California, recently suggested that RXR [rentinoid X receptor]-selective retinoids, rather than classical retinoids, may be able to overcome nicotine-related inhibition of tumor suppression, tumor providing a novel way to treat or prevent lung cancer.
In preliminary studies of lung cancer, G.Q. Chen and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.